ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1425	National Cancer Institute	Html	en	Ewing Sarcoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of Ewing sarcoma.	ewing sarcoma 0.955451 Localized Ewing Sarcoma 0.516622 standard-risk Ewing sarcoma 0.50921 localized ewing tumors 0.458678 pelvic ewing sarcoma 0.53548 non-metastatic ewing 0.447666 Ewing family tumors 0.476484 Cooperative Ewing Sarcoma 0.57252 Primary Ewing tumor 0.442949 genetically confirmed Ewing 0.443739 recurrent Ewing sarcoma 0.50281 high-risk Ewing sarcoma 0.510965 soft tissue ewing 0.474262 Ewing sarcoma regimen 0.517079 Sarcoma Studies patients 0.436849 sarcoma treatment 0.437736 ewing sarcoma family 0.677203 Ewing sarcoma patients 0.582131 Ewing tumor patients 0.46609 Ewing Sarcoma Study 0.512708 radiation therapy 0.475396 Cutaneous Ewing sarcoma 0.543452 Ewing sarcoma trials 0.520061 extraosseous Ewing sarcoma. 0.438839 et al. 0.575718	extraskeletal Ewing sarcoma 0.55299 tissue Ewing sarcoma 0.517715 sarcoma family tumors 0.500986 Ewing sarcoma molecularly. 0.525686 nonmetastatic Ewing sarcoma 0.582468 secondary Ewing sarcoma 0.532715 PUBMED Abstract 0.436153 extraosseus Ewing tumors 0.450361 extraosseous ewing sarcoma 0.608612 Pediatr Blood Cancer 0.643087 prognosis Ewing family 0.435199 Intergroup Cooperative Ewing 0.452427 advanced Ewing tumors 0.44875 nonmetastatic extraosseous Ewing 0.439621 subcutaneous Ewing sarcoma 0.543232 Ewing sarcoma. 0.468942 primary Ewing sarcoma 0.527784 Abstract 0.588175 Clin Oncol 0.669349 multifocal Ewing sarcoma 0.559473 metastatic Ewing tumors 0.450872 Ewing tumor 0.52176 ewing tumors 0.573464 non metastatic Ewing 0.435213	CLICK HERE
1493	National Cancer Institute	Html	en	Oropharyngeal Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of oropharyngeal cancer.	neck radiotherapy 0.359364 locally advanced head 0.471621 Engl J Med 0.53665 American Cancer Society 0.443811 well-lateralized oropharyngeal cancer 0.401103 neck radiation therapy 0.384516 Int J Radiat 0.508851 neck cancer patients 0.486158 squamous cell cancer 0.411067 Radiat Oncol Biol 0.753309 DeVita VT Jr 0.383261 Natl Cancer Inst 0.447951 neck cancers 0.433823 Clin Cancer Res 0.390283 radiation therapy 0.610067 human papillomavirus 0.44587 smoking-related oropharyngeal cancer 0.443579 HPV-positive oropharyngeal cancer 0.448716 et al. 0.570118 Mendenhall WM 0.369324 Cancer Genet Cytogenet 0.359903 Head Neck 0.484421 index nonoropharyngeal cancer 0.350094 Oropharyngeal tumors 0.352557 index oropharyngeal SCC 0.386084	neck SCC 0.359598 oropharyngeal cancers 0.476599 HPV-positive oropharyngeal cancers 0.469127 anterior tonsillar pillar 0.378606 Cancer Epidemiol Biomarkers 0.378376 neck squamous cell 0.377126 head 0.534685 PUBMED Abstract 0.462256 early-stage oropharyngeal cancer 0.392101 Otolaryngol Head Neck 0.404239 index oropharyngeal cancers 0.372661 -positive oropharyngeal cancers 0.363257 neck retinoid chemoprevention 0.355793 Abstract 0.60039 Clin Oncol 0.357598 Oncol Biol Phys 0.772447 squamous cell carcinomas 0.385763 primary tumor 0.372966 field cancerization 0.370643 neck cancer 0.957961 neck tumors 0.340144 oropharyngeal cancer 0.807108 oropharyngeal SCC 0.391565 oropharyngeal cancer incidence 0.417437	CLICK HERE
1534	National Cancer Institute	Html	en	Cartilage (Bovine and Shark) (PDQ®)–Health Professional Version	Expert-reviewed information summary about the use of bovine and shark cartilage as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	angiogenesis inhibitor 0.605921 cartilage factor 0.525431 cartilage research 0.52625 cartilage powder 0.542054 cartilage treatment 0.554222 shark cartilage 0.973124 shark cartilage extracts 0.55218 Biol Response Mod 0.51035 cartilage cells 0.557954 new blood vessels 0.487052 tumor angiogenesis 0.46716 dry shark cartilage 0.564932 bovine cartilage 0.627952 patients 0.494925 Natl Cancer Inst 0.505572 vascular endothelial growth 0.488146 novel shark cartilage 0.566963 bovine cartilage extract 0.544409 bovine cartilage extracts 0.534781 shark cartilage extract 0.575893 powdered shark cartilage 0.660454 metastatic renal cell 0.492793 Japanese shark cartilage 0.557325 new endothelial cells 0.468808	shark cartilage products 0.552328 endothelial cells 0.499823 cartilage products 0.616806 Oral shark cartilage 0.568829 angiogenesis inhibitors 0.486536 PUBMED Abstract 0.506075 epiphyseal cartilage 0.523025 cartilage tissue 0.520334 endothelial cell proliferation 0.510942 bovine cartilage preparations 0.556431 human cartilage 0.516475 shark cartilage-derived angiogenesis 0.484691 Catrix treatment 0.468204 shark cartilage product 0.595815 cartilage therapy 0.532177 Abstract 0.525209 endothelial cell 0.516176 renal cell carcinoma 0.554811 phase i/ii trial 0.471371 cartilage-derived collagenase inhibitor 0.469151 tumor 0.475092 shark cartilage inhibitor 0.566866 cancer 0.518101 bovine cartilage therapies 0.544621	CLICK HERE
1562	National Cancer Institute	Html	en	Hypopharyngeal Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of hypopharyngeal cancer.	cancer treatment 0.321266 high-dose radiation therapy 0.323579 centimeters 0.269921 cancer spreads 0.270417 malignant tumor cells 0.281954 body 0.305644 chemotherapy 0.290118 PDQ cancer information 0.346817 stage III hypopharyngeal 0.274417 clinical trial search 0.347149 clinical trials 0.698171 hypopharynx 0.280224 cancer information summary 0.319294 metastatic hypopharyngeal cancer 0.310093 clinical trial 0.551798 Recurrent hypopharyngeal cancer 0.306668 patients 0.317052 stage IV hypopharyngeal 0.274937 nearby soft tissue 0.271159 treatment clinical trial 0.275593 NCI PDQ cancer 0.283768 radiation therapy 0.705932 Treatment Editorial Board 0.281401 General information 0.289657 hypopharyngeal cancer 0.722179	general cancer information 0.275426 treatment 0.442202 new cancer treatments 0.272872 NCI-supported cancer 0.296123 cancer cells 0.361641 Cancer Information Service 0.276024 patient 0.26688 lymph nodes 0.350794 treatment clinical trials 0.300384 National Cancer Institute 0.364736 swollen lymph nodes 0.277694 new treatment 0.302418 External radiation therapy 0.314938 neck 0.309398 cancer research process 0.269057 cancer clinical trials 0.358746 stage 0.310003 neck cancer 0.286172 lymph node 0.322344 cancer information summaries 0.27414 comprehensive cancer information 0.274558 cancer 0.901171 standard treatment 0.274055 Hypopharyngeal Cancer Treatment 0.314822	CLICK HERE
1664	National Cancer Institute	Html	en	Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood atypical teratoid/rhabdoid tumors	cancer treatment 0.542006 metastatic brain tumors 0.391418 ongoing clinical trials 0.389415 PDQ cancer information 0.511527 tumor suppressor genes 0.452709 clinical trial search 0.399694 brain tumors 0.444671 CNS atypical teratoid/rhabdoid 0.388691 clinical trials 0.847224 Pediatric Treatment Editorial 0.416481 Teratoid/Rhabdoid Tumor Treatment 0.445097 cancer information summary 0.463674 clinical trial 0.521041 cancer cells 0.510172 stem cell transplant 0.396934 patients 0.411179 primary brain tumors 0.3918 treatment clinical trial 0.409064 NCI PDQ cancer 0.42324 radiation therapy 0.555658 Treatment Editorial Board 0.420841 Cord Tumors Treatment 0.414346 late effects 0.393798 treatment 0.689522 new cancer treatments 0.395428	PDQ treatment summary 0.447943 childhood brain 0.385451 Cancer Information Service 0.399251 specific cancer cells 0.397642 PDQ Pediatric Treatment 0.40786 treatment clinical trials 0.444124 National Cancer Institute 0.458723 spinal cord 0.616147 tumor cells 0.437516 effects cancer treatment 0.421518 new treatment 0.427513 childhood cancer information 0.400212 External radiation therapy 0.395094 brain tumor 0.405279 brain 0.467984 atypical teratoid/rhabdoid tumor 0.982554 PDQ summary 0.439127 cancer clinical trials 0.434177 cancer information summaries 0.39809 comprehensive cancer information 0.397631 cancer 0.740574 appropriate cancer treatment 0.419383 standard treatment 0.391688 fast-growing tumor 0.388774	CLICK HERE
1868	National Cancer Institute	Html	es	Tratamiento del linfoma de Hodgkin infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del linfoma de Hodgkin infantil.	lymphocyte predominant hodgkin 0.379318 Cancer Statistics Review 0.310924 patients with hodgkin 0.340461 Epstein-Barr virus with 0.308343 lymphocyte predominance hodgkin 0.361894 Pediatric Lymphocyte-Predominant Hodgkin 0.335497 with nodular lymphocyte 0.31309 Epstein-Barr virus 0.324897 localized childhood hodgkin 0.334572 familial classical hodgkin 0.33579 células reed-sternberg 0.313182 Radiat Oncol Biol 0.310379 oncology group study 0.317944 adolescent hodgkin 0.33572 Children's Oncology Group 0.329911 Estados Unidos 0.310464 siguientes características 0.32336 Leuk Lymphoma 0.318529 hodgkin's lymphoma 0.723879 childhood hodgkin 0.361352 SEER Cancer Statistics 0.312001 classic hodgkin 0.335243 pediatric hodgkin 0.427701 IV Hodgkin 0.334995 adultos jóvenes 0.32544	estadio iv 0.319107 nodular lymphocyte-predominant hodgkin 0.387944 nodular sclerosing hodgkin 0.337374 high-risk hodgkin 0.334348 pediatric patients with 0.317448 with hodgkin 0.425646 linfadenopatía periférica 0.308361 non-Hodgkin's lymphoma 0.3114 advanced hodgkin 0.335086 National Cancer Institute 0.316464 report from 0.308961 with classical hodgkin 0.37144 Hodgkin's lymphoma after 0.346052 Epstein-Barr virus infection 0.309022 células reed-sternberg llamadas 0.308458 Pediatr Hematol Oncol 0.310971 Lymphoma project 0.310216 Clin Oncol 0.390721 Hodgkin Lymphoma Group 0.341816 Oncol Biol Phys 0.310469 hodgkin lymphoma 0.986519 lymphocyte-predominant hodgkin lymphoma 0.45063 Cancer Institute 0.316934 classical hodgkin lymphoma 0.529436	CLICK HERE
1883	National Cancer Institute	Html	es	Tratamiento de los tumores extracraneales de células germinativas en la niñez (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los tumores extracraneales de células germinativas en la niñez.	cell tumor protocols 0.408279 germinativas malignas localización 0.405353 células germinativas seminomatosos.Seminoma 0.410393 cell tumor combined 0.407867 germ cell tumours 0.412186 Perlman EJ 0.405253 Calaminus G 0.412513 Cell Cancer Collaborative 0.406794 cell tumors from 0.406747 Göbel U 0.406021 Cancer Group 0.42074 cell tumor studies 0.407558 pediatric oncology 0.41388 células germinativas mixtos 0.417539 International Germ Cell 0.417008 Children's Oncology Group 0.409014 mediastinal germ 0.406328 cell tumor study 0.408368 <2 cm 0.405406 Metástasis peritoneales macroscópicas 0.405941 germ cell neoplasms 0.406391 Children's Cancer 0.42175 cell tumors show 0.406094 pediatric germ 0.426106 adultos jóvenes 0.40725	estadio iv 0.405826 ganglios linfáticos ≥2 0.411723 Germ Cell Consensus 0.412507 Cushing B 0.405386 teratomas benignos 0.407141 Genes Chromosomes Cancer 0.438953 with germ 0.406335 malignant germ cell 0.462527 PDQ Tratamiento 0.405882 childhood germ 0.409831 cell tumors based 0.405903 Clin Oncol 0.444548 saco vitelino 0.435575 linfáticos ≥2 cm 0.408554 Schneider DT 0.409517 Children's Cancer Group 0.419331 Cell Consensus Classification 0.409901 germ cell tumors 0.974328 Kingdom Children Cancer 0.408316 germ cell cancer 0.410294 Children's Cancer Study 0.409136 pediatric oncology group 0.410202 oncology group 0.420408 Cancer Study Group 0.411644	CLICK HERE
2000	National Cancer Institute	Html	es	Tratamiento de la histiocitosis de células de Langerhans (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la histiocitosis de células de Langerhans.	cuánto aire 0.415134 siguientes procedimientos 0.528715 células madre 0.858073 adultos jóvenes 0.464664 efectos secundarios meses 0.439126 siguientes aspectos 0.434701 faja ajustadora 0.428231 HCL infantil multisistémica 0.546722 cuántos sistemas 0.518567 genes ras 0.453948 pequeña cantidad 0.423844 células normales.ampliar exploración 0.532323 vía oral 0.42013 rayos x 0.425227 gen braf 0.666188 largo plazo 0.44968 cuántas células 0.518957 niño ayuda 0.426203 efectos tardíos 0.516221 escáner.ampliar exploración 0.429231 tarde.ampliar ecografía 0.427113	vías respiratorias 0.424871 causa problemas 0.424997 lesiones óseas 0.423193 National Cancer Institute 0.417904 IRMN).Ampliar Imágenes 0.421648 siguientes riesgos 0.415861 radiación uvb 0.414555 Instituto Nacional 0.431398 PDQ Tratamiento 0.451873 antecedentes familiares 0.589915 llamada genes ras 0.432872 explorador tep 0.430081 terapia fotodinámica causa 0.453098 sistema nervioso central 0.604707 Physician Data Query 0.464236 mayores probabilidades 0.416225 HCL multisistémica 0.966875 terapia fotodinámica llamada 0.451949 radiación ultravioleta 0.561342 siguientes pruebas 0.489919	CLICK HERE
3432	National Cancer Institute	Html	es	Formaldehído y el riesgo de cáncer	Hoja informativa que trata sobre el formaldehído y su posible relación con el cáncer. Incluye recursos para consultar mayor información.	leucemia mieloide 0.978153 malignancies among workers 0.549063 TW Alexander Drive 0.542382 exterior-grade” pressed-wood 0.527538 cancers among workers 0.548254 Programa Nacional 0.567373 largo plazo 0.580439 Protección Ambiental 0.673926 Salud Ocupacional 0.583378 Mortality from 0.576068 Instituto Nacional 0.645898 Indoor Air 0.527731 pequeñas cantidades 0.52948 Lubin JH 0.573228 posibles efectos 0.584035 Estados Unidos 0.527658 PubMed Abstract 0.744149 Cancer Institute Cohort 0.547453 East West Highway 0.542743 International Agency 0.53583 Environmental Protection Agency 0.819165 probable carcinógeno 0.619447 Product Safety Commission 0.830336 among workers 0.572581 New Hampshire Avenue 0.541693	aislamiento uffi 0.536299 National Toxicology Program 0.804784 Drug Administration 0.579636 Environmental Health Sciences 0.548429 Occupational Environmental Medicine 0.553867 Mortality among 0.531703 Occupational Safety 0.816569 materiales aislantes 0.528932 British chemical workers 0.549313 Emergency Management Agency 0.637566 vías respiratorias 0.526175 National Cancer Institute 0.733699 National Institute 0.579158 aislamiento tipo uffi 0.553887 Health Administration 0.662185 Consumer Product Safety 0.833221 Indoor Environments Division 0.548156 corto plazo 0.574665 garment workers 0.530046 Blair A 0.564637 cabo estudios 0.530631 12.º informe 0.526826 Federal Emergency Management 0.627002 Institutos Nacionales 0.577211	CLICK HERE
15640	National Cancer Institute	Html	null	Research & Development (R&D) Contracts	null			CLICK HERE